NEWARK, DE | The Subcutaneous Bispecific Antibody Auto-Injectors Market is valued at USD 24.2 million in 2025 and is projected to reach USD 30.0 million in 2026, expanding at a CAGR of 24.0% through 2036. The market is expected to achieve USD 257.8 million by 2036, driven by the transition from intravenous biologics delivery toward localized subcutaneous administration formats....